2015
DOI: 10.1016/j.yexmp.2014.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(10 citation statements)
references
References 39 publications
0
9
0
Order By: Relevance
“…MDM2 encodes an ubiquitin ligase, which marks tumor suppressor proteins such as p53 for proteasomal degradation; its overexpression has been associated with increased susceptibility to tumor formation [42]. LIPC encodes a hepatic lipase with hydrolase activity for triglycerides and variants of this gene have been implicated in increased risk of cardiovascular disease [43] and T2D [44]. MAPK1 (also called p38-MAPK) is a member of the serine/threonine kinase, which acts as an essential component of the MAP kinase signal transduction pathway.…”
Section: Discussionmentioning
confidence: 99%
“…MDM2 encodes an ubiquitin ligase, which marks tumor suppressor proteins such as p53 for proteasomal degradation; its overexpression has been associated with increased susceptibility to tumor formation [42]. LIPC encodes a hepatic lipase with hydrolase activity for triglycerides and variants of this gene have been implicated in increased risk of cardiovascular disease [43] and T2D [44]. MAPK1 (also called p38-MAPK) is a member of the serine/threonine kinase, which acts as an essential component of the MAP kinase signal transduction pathway.…”
Section: Discussionmentioning
confidence: 99%
“…[17] The influence that this gene has on the metabolism of glycerophospholipids[49] may also alter plasma concentrations thereof. Results published by Posadas-Sánchez et al [50] suggested that the LIPC C-154T polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors: under dominant model, the TT genotype was associated with increased levels of triglycerides/HDL-c index ( P = 0.046). On the other hand, the same genotype was associated with the presence of small LDLs ( P = 0.003).…”
Section: Discussionmentioning
confidence: 98%
“…Since the metabolism of glycerophospholipids is influenced by the hepatic lipase gene, it is believed that it may also alter HDL-cholesterol plasma concentrations [42]. As suggested by Posadas-Sanchez et al [43], the TT genotype of LIPC C-154T polymorphism is related to higher levels of triglycerides/HDL-cholesterol index ( p = 0.046) and triglycerides ( p = 0.0002), under a dominant model. Since the metabolism of glycerophospholipids is influenced by the hepatic lipase gene, it is believed that it may also alter HDL-cholesterol plasma concentrations [42].…”
Section: Discussionmentioning
confidence: 99%